"Leukemia, B-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant disease of the B-LYMPHOCYTES in the bone marrow and/or blood.
| Descriptor ID |
D015448
|
| MeSH Number(s) |
C04.557.337.428.080 C15.604.515.560.080 C20.683.515.528.080
|
| Concept/Terms |
Leukemia, B-Cell- Leukemia, B-Cell
- Leukemia, B Cell
- Lymphocytic Leukemia, B-Cell
- B-Cell Lymphocytic Leukemia
- B-Cell Lymphocytic Leukemias
- Leukemia, B-Cell Lymphocytic
- Leukemias, B-Cell Lymphocytic
- Lymphocytic Leukemia, B Cell
- Lymphocytic Leukemias, B-Cell
- Leukemia, Lymphocytic, B Cell
- Leukemia, Lymphocytic, B-Cell
- B-Cell Leukemia
- B Cell Leukemia
- B-Cell Leukemias
- Leukemias, B-Cell
- B-Lymphocytic Leukemia
- B Lymphocytic Leukemia
- B-Lymphocytic Leukemias
- Leukemia, B-Lymphocytic
- Leukemias, B-Lymphocytic
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, B-Cell".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, B-Cell".
This graph shows the total number of publications written about "Leukemia, B-Cell" by people in this website by year, and whether "Leukemia, B-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 2 | 0 | 2 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 1 | 2 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, B-Cell" by people in Profiles.
-
Genomic trajectory in leukemogenesis of myeloproliferative neoplasms: a case report. BMC Med Genomics. 2021 May 22; 14(1):137.
-
Targeting Bruton's tyrosine kinase with ibrutinib in B-cell malignancies. Clin Pharmacol Ther. 2015 May; 97(5):455-68.
-
Differential expression of CD200 in B-cell neoplasms by flow cytometry can assist in diagnosis, subclassification, and bone marrow staging. Am J Clin Pathol. 2014 Dec; 142(6):837-44.
-
Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms. Arch Pathol Lab Med. 2014 Jul; 138(7):903-9.
-
Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia. PLoS One. 2013; 8(4):e61807.
-
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation. Blood. 2010 Apr 01; 115(13):2695-703.
-
A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol Rev. 2006 Apr; 210:67-85.
-
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 1):6916-23.
-
Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis. Blood. 2005 May 15; 105(10):3987-94.
-
Molecular monitoring of cerebrospinal fluid can predict clinical relapse in acute lymphoblastic leukemia with eosinophilia. Arch Pathol Lab Med. 2003 May; 127(5):601-5.